logo
February 6 - 9, 2020 | Orlando

Emerald Health Group

Booth: 706

Emerald is focused on the development of pharmaceutical, botanical, and nutraceutical products that may provide wellness and medical benefits by interacting with the endocannabinoid system. The near-term investment opportunities within our portfolio are: Emerald Health Therapeutics (TSXV: EMH; OTCQX: EMHTF), a licensed producer of cannabis for medical and recreational purposes; Emerald Bioscience (OTCQB: EMBI), a biopharmaceutical company developing cannabinoid-based therapeutics; and Emerald Health Pharmaceuticals, a pre-IPO biopharmaceutical company developing treatments for autoimmune diseases.

Speaker Schedule

Enhancing Health Through Cannabis Science
February 8, 2019, 11:55 am - 12:15 pm EST

Presented by: Rob Hill, CPA

Focus: CANNABIS INVESTMENTS

The Scientific and Investment Potential of Cannabinoids
February 9, 2019, 8:00 am - 8:45 am EST

Presented by: Jim DeMesa, MD, MBA

Focus: CANNABIS INVESTMENTS